16hon MSN
Heron Therapeutics outlines $153M–$163M net revenue target as acute care momentum accelerates
Acute care net sales rose from $10.7 million in Q2 to $12.3 million in Q3, with ZYNRELEF and APONVIE both showing strong year-over-year growth. SUSTOL's decline and planned wind-down were more ...
Norway’s sovereign wealth fund, one of Tesla’s biggest investors says it will vote against a proposed compensation package ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback